These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1073 related articles for article (PubMed ID: 29980607)

  • 41. The fecal microbiota transplantation response differs between patients with severe and moderate irritable bowel symptoms.
    El-Salhy M; Mazzawi T; Hausken T; Hatlebakk JG
    Scand J Gastroenterol; 2022 Sep; 57(9):1036-1045. PubMed ID: 35486073
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of Clostridium butyricum on symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
    Sun YY; Li M; Li YY; Li LX; Zhai WZ; Wang P; Yang XX; Gu X; Song LJ; Li Z; Zuo XL; Li YQ
    Sci Rep; 2018 Feb; 8(1):2964. PubMed ID: 29445178
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome Patients: An Updated Systematic Review and Meta-Analysis.
    Elhusein AM; Fadlalmola HA
    Gastroenterol Nurs; 2022 Jan-Feb 01; 45(1):11-20. PubMed ID: 35108241
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
    Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
    J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Can fecal microbiota transplantation cure irritable bowel syndrome?
    Halkjær SI; Boolsen AW; Günther S; Christensen AH; Petersen AM
    World J Gastroenterol; 2017 Jun; 23(22):4112-4120. PubMed ID: 28652664
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of fecal microbiota transplantation on psychiatric symptoms among patients with irritable bowel syndrome, functional diarrhea and functional constipation: An open-label observational study.
    Kurokawa S; Kishimoto T; Mizuno S; Masaoka T; Naganuma M; Liang KC; Kitazawa M; Nakashima M; Shindo C; Suda W; Hattori M; Kanai T; Mimura M
    J Affect Disord; 2018 Aug; 235():506-512. PubMed ID: 29684865
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial.
    Paramsothy S; Kamm MA; Kaakoush NO; Walsh AJ; van den Bogaerde J; Samuel D; Leong RWL; Connor S; Ng W; Paramsothy R; Xuan W; Lin E; Mitchell HM; Borody TJ
    Lancet; 2017 Mar; 389(10075):1218-1228. PubMed ID: 28214091
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A randomized placebo-controlled clinical trial of a multi-strain probiotic formulation (Bio-Kult®) in the management of diarrhea-predominant irritable bowel syndrome.
    Ishaque SM; Khosruzzaman SM; Ahmed DS; Sah MP
    BMC Gastroenterol; 2018 May; 18(1):71. PubMed ID: 29801486
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Randomised clinical trial: A liquid multi-strain probiotic vs. placebo in the irritable bowel syndrome--a 12 week double-blind study.
    Sisson G; Ayis S; Sherwood RA; Bjarnason I
    Aliment Pharmacol Ther; 2014 Jul; 40(1):51-62. PubMed ID: 24815298
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multivariate modelling of faecal bacterial profiles of patients with IBS predicts responsiveness to a diet low in FODMAPs.
    Bennet SMP; Böhn L; Störsrud S; Liljebo T; Collin L; Lindfors P; Törnblom H; Öhman L; Simrén M
    Gut; 2018 May; 67(5):872-881. PubMed ID: 28416515
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fecal microbiota transplant delivered via invasive routes in irritable bowel syndrome: A systematic review and meta-analysis of randomized controlled trials.
    Mohan BP; Loganathan P; Khan SR; Garg G; Muthusamy A; Ponnada S; Pasam RT; Chandan S; Tuteja A
    Indian J Gastroenterol; 2023 Jun; 42(3):315-323. PubMed ID: 37247177
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Does Fibre-fix provided to people with irritable bowel syndrome who are consuming a low FODMAP diet improve their gut health, gut microbiome, sleep and mental health? A double-blinded, randomised controlled trial.
    Yan R; Murphy M; Genoni A; Marlow E; Dunican IC; Lo J; Andrew L; Devine A; Christophersen CT
    BMJ Open Gastroenterol; 2020 Aug; 7(1):. PubMed ID: 32816830
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increasing the transplant dose and repeating faecal microbiota transplantation results in the responses of male patients with IBS reaching those of females.
    El-Salhy M; Gilja OH; Hatlebakk JG
    Scand J Gastroenterol; 2024 Apr; 59(4):391-400. PubMed ID: 38084725
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fecal Microbiota Transplantation Combined with a Low FODMAP Diet for the Treatment of Irritable Bowel Syndrome with Predominant Diarrhea.
    Huang HL; Zhu JQ; Yang LS; Wu Q; Shou DW; Chen HT; Ma J; Li YQ; Xu HM; Zhou YJ
    Oxid Med Cell Longev; 2022; 2022():5121496. PubMed ID: 36187337
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fecal microbiota transplantation for irritable bowel syndrome: Current evidence and perspectives.
    Dai C; Huang YH; Jiang M
    World J Gastroenterol; 2024 Apr; 30(16):2179-2183. PubMed ID: 38690018
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dynamic changes of intestinal flora in patients with irritable bowel syndrome combined with anxiety and depression after oral administration of enterobacteria capsules.
    Guo Q; Lin H; Chen P; Tan S; Wen Z; Lin L; He J; Wen J; Lu S
    Bioengineered; 2021 Dec; 12(2):11885-11897. PubMed ID: 34923901
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Washed microbiota transplantation targeting both gastrointestinal and extraintestinal symptoms in patients with irritable bowel syndrome.
    Zhang Z; Li Q; Zhang S; Liu Y; Lu G; Wen Q; Cui B; Zhang F; Zhang F
    Prog Neuropsychopharmacol Biol Psychiatry; 2023 Dec; 127():110839. PubMed ID: 37562707
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Jamshidi P; Farsi Y; Nariman Z; Hatamnejad MR; Mohammadzadeh B; Akbarialiabad H; Nasiri MJ; Sechi LA
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834010
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Effect of Anaerobically Cultivated Human Intestinal Microbiota Compared to Fecal Microbiota Transplantation on Gut Microbiota Profile and Symptoms of Irritable Bowel Syndrome, a Double-Blind Placebo-Controlled Study.
    Mazzawi T; Hausken T; Refsnes PF; Hatlebakk JG; Lied GA
    Microorganisms; 2022 Sep; 10(9):. PubMed ID: 36144420
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gut microbiota and therapeutic approaches for dysbiosis in irritable bowel syndrome: recent developments and future perspectives.
    Dale HF; Lied GA
    Turk J Med Sci; 2020 Nov; 50(SI-2):1632-1641. PubMed ID: 32222124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 54.